In addition, although not yet recognized by the WHO classification, there are some patients with clinical features attributable to IgM monoclonal protein but no evidence of lymphoma (IgM-related disorders) who should also be considered for BM evaluation to rule out a WM [1]. The gene discussed is CD40LG; the disease is lymphoma.